|
Volumn 12, Issue 4, 2006, Pages 379-380
|
Reply to 'Hormone in the hot seat' [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
ESTRADIOL;
ESTROGEN;
ESTROGEN RECEPTOR;
HORMONE;
MEDROXYPROGESTERONE ACETATE;
NEUROPROTECTIVE AGENT;
PROGESTERONE;
STEROID HORMONE;
ALZHEIMER DISEASE;
BRAIN FUNCTION;
CEREBROVASCULAR ACCIDENT;
COGNITION;
ESTROGEN URINE LEVEL;
HEALTH CARE ORGANIZATION;
HEALTH SERVICE;
HEALTH STATUS;
HEART;
HORMONE ACTION;
HORMONE SUBSTITUTION;
HUMAN;
LETTER;
MOTOR PERFORMANCE;
MULTIPLE SCLEROSIS;
NEUROPROTECTION;
NONHUMAN;
OVARY CYCLE;
PAIN;
PARKINSON DISEASE;
POSTMENOPAUSE;
PRIORITY JOURNAL;
SEIZURE;
AGED;
BRAIN;
DATA INTERPRETATION, STATISTICAL;
ESTROGENS;
FEMALE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
POSTMENOPAUSE;
PROGESTERONE;
RECEPTORS, ESTROGEN;
WOMEN'S HEALTH;
|
EID: 33645739681
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0406-379b Document Type: Letter |
Times cited : (7)
|
References (0)
|